SEC Form 4 · accession 0001140361-15-043484
BioRestorative Therapies, Inc. · BRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John M Desmarais
Director
Period of report
Dec 1, 2015
Accepted (ET)
Dec 3, 2015 · 11:05 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001505497
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 125,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionF1 | $4.40 | Dec 1, 2015 | A | 15,000 | A | — | Dec 1, 2025 | Common Stock | 15,000 | 15,000 | D |
| Warrant | $5.00 | holding | — | — | — | Dec 17, 2015 | Nov 17, 2020 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1The option vests to the extent of 5,000 shares on each of December 1, 2016, 2017 and 2018.